Tara Sanft

Phase I/II Trial of Exemestane, Ribociclib, and Everolimus in Women with HR+/HER2− Advanced Breast Cancer after Progression on CDK4/6 Inhibitors (TRINITI-1)

Aditya Bardia, Sara A. Hurvitz, Angela DeMichele et al. · Clinical Cancer Research · 2021 · 113 citations · Full text

Medicine, Oncology, Pharmacology +17

Datopotamab–deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial

Rebecca Shatsky, Meghna S. Trivedi, Christina Yau et al. · Nature Medicine · 2024 · 40 citations · Full text

Medicine, Oncology, Pharmacology +12

Association between pre-diagnosis BMI, physical activity, pathologic complete response, and chemotherapy completion in women treated with neoadjuvant chemotherapy for breast cancer

Ilana M. Usiskin, Fangyong Li, Melinda L. Irwin et al. · Breast Cancer · 2019 · 31 citations

Medicine, Oncology, Breast Oncology +12

Exercise and Nutrition to Improve Cancer Treatment-Related Outcomes (ENICTO)

Kathryn H. Schmitz, Justin C. Brown, Melinda L. Irwin et al. · JNCI Journal of the National Cancer Institute · 2024 · 28 citations · Full text

Medicine, Oncology, Chemotherapy +16

Antibiotic therapy is associated with adverse drug events among older adults with advanced cancer: A cohort study

Rupak Datta, Ling Han, Margaret Doyle et al. · Palliative Medicine · 2023 · 12 citations

Medicine, Oncology, Pharmacology +16